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VITAMIN K. TREATMENT OF BROD IF ACOUM POISONING IN DOGS 
C.G. MACKINTOSH and F.J. LAAS, lnvennay Agricultural Research Centre, Private Bag, Mosgiel, New Zealand. 
M.E.R. GODFREY, J.T. Eaton & Co., Inc. 1393 E. Highland Rd., Twinsburg, Ohio44087. 
K. TURNER, lnvennay Animal Health Laboratory, Private Bag, Mosgiel, New Zealand. 
ABSTRACT: Twenty dogs received a potentially lethal (15 mg/kg) dose of brodifacoum, a halogenated coumarin-type 
anticoagulant poison. Eleven were immediately treated with vitamin K1 daily for 5 days, either by intramuscular injections 
(2 mg/kg) or oral tablets (1 mg/kg). It was necessary to give further doses of vitamin K1 to most of the dogs for up to 2 weeks 
after the first treatment period to reduce their P times to normal levels(< 10 seconds). Four dogs were not given further vitamin 
K, and two of these died of acute blood loss from an intrathoracic hemorrhage. Nine dogs received vitamin K1 (2 mg/kg by 
intramuscular injection) when clinical signs of anticoagulant poisoning were observed. Two dogs died suddenly without pre-
monitory clinical signs of poisoning. The remaining 7 dogs showed various signs of anticoagulant poisoning 4 to 8 days after 
dosing and they received a 5 day course of vitamin K 1• After this period one dog had a transient rise in its P time but this 
returned to normal without treatment, while another dog was treated on days 16, 20, 29 and 30. In conclusion, the authors 
recommended vitamin K1 therapy, 2 mg/kg by tablet or injection, daily for 3 weeks in cases of known or suspected 
brodifacoum poisoning in dogs. 
INTRODUCTION 
Brodifacoum, a halogenated coumarin derivative, is 
currently marketed as a rodenticide and has recently been 
shown to be suitable for rabbit control under New 7.ealand 
conditions (Godfrey and Lyman 1980, Godfrey et al. 1981 a, 
Rammell et al. 1984 ). The most commonly used poison to 
control rabbits at the moment is sodium monofluoroacetate 
( 1080), and dogs, which are highly susceptible to this poison, 
frequently die after ingesting bait material or poisoned 
animals (Rammell and Fleming 1978). Death usually occurs 
within 12 hours and there is no antidote. Brodifacoum is 
considerably less toxic for dogs than 1080 (LDso 3.56 and 0.5 
mg/kg respectively) whereas the LD50 in rabbits is very 
similar (0.5 and 0.7 mg/kg respectively) (Mount et al. 1982, 
Godfreyetal.1981b,RammellandFleming 1978). Thus the 
risk of a dog ingesting a lethal dose ofbrodifacoum is less than 
for 1080. Commercial baits contain 50 mg brodifacoum per 
kg bait and therefore a 20-kg dog would have to consume 1.5 
kg of bait to receive an acute LD50 dose. However, there is 
considerable variation between individuals in their response 
to anticoagulant poisoning (Coon and Willis 1970) and some 
dogs may be clinically affected with smaller doses. A number 
of dogs have been poisoned after consuming as few as 8 Talon 
baits (Montgomery, pers. comm.). As with all anticoagulant 
poisons there is a 2- to 3-day delay before a fall in blood 
clotting factors and the onset of clinical signs which may 
include lassitude, anorexia, a bloody nasal discharge, rapid 
thready pulse, pallid mucous membranes, rapid respiration 
and petechial hemorrhages in the oral and conjunctiva) 
mucous membranes. These signs should alen the owner and 
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veterinarian to the possibility of anticoagulant poisoning. 
All anticoagulants derived from coumarin are slructur-
ally related to vitamin Kand interfere with the normal blood-
clotting mechanism by inhibiting the vitamin K dependent 
synthesis of clotting factors II (prothrombin), VII, IX and X 
(Park et al. 1979). Thus measurement of the prothrombin 
time (P time) is a good indication of the degree of anticoagu-
lant activity. The normal P time for a dog is< 10 seconds. The 
administration of vitamin K1 appreciably reduces a pro-
longed prothrombic time within 4 to 8 hours of administra-
tion. Vitamin K 1 acts on a competitive basis and larger doses 
are required to reverse higher doses of anticoagulant (Coon 
and Willis 1970). There are a number of similar analogues 
of naturally occurring Vitamin K1 which are reputed to have 
the same activity. However, Clark and Halliwell (1963) 
demonstrated that a number of commercially available wa-
ter- soluble analogues, such as vitamin ~. have litlle or no 
value for treating anticoagulant poisoning. This is probably 
because of their more rapid conjugation and excretion (Coon 
and Willis 1970). 
The "first generation" anticoagulant rodenticides of the 
coumarin type include warfarin, and their activity lasts for up 
to 4 days (Coon and Willis 1970, Mount et al. 1982); 
therefore, vitamin K1 therapy (1 to 2 mg/kg) daily for a 
minimum of 4 days has been recommended (Clark and 
Halliwell 1963). "Second generation" anticoagulants such as 
brodifacoum appear to be cleared from the body more slowly 
and they are pharmacologically active longer. Tissue resi-
dues have been detected in the livers of sheep for up to 4 
months after they were dosed with brodifacoum al 2 mg/kg, 
although these animals showed no clinical signs of anticoagu-
lant poisoning (Laas et al. 1985). Anticoagulant activity has 
been detected in rabbits 6 weeks afier they were dosed with 1 
mg/kg brodiracoum (Park and Leck 1982). However there is 
no published information on the duration of brodifacoum 
activity in dogs nor on the recommendations for treatment of 
dogs poisoned with it. Therefore, the objective of this trial was 
to investigate the dose and duration of vitamin K, necessary to 
treat dogs acutely poisoned with a potentially lethal dose of 
brodifacoum. 
MATERIALS AND METHODS 
Twenty-one dogs of mixed age, breed and sex were 
individuallyhousedinkennels,fedmuuondailyandhadwater 
freely available. They all received a sandwich of bread and 
margarine containing brodlfacoum at a dose rate of 15 mg/kg 
which is approximately 4 times the LD,0 (Godfrey et al. 
1981b). There were 3 treatment regimes: 
Groull I: Five dogs received vitamin K, (2 mg/kg) by 
intramuscular(IM) injection daily for 5 days commencing the 
day after dosing. (The source of K1 was Konakion - Roche 
Products (New Zealand) Lid, Auckland, New Zealand). 
Group 2: Six dogs received vitamin K1 (I mg/kg) orally by 
tablet daily for 5 days commencing the day afier dosing. 
Qrogp 3: Ten dogs were observed daily for obvious clinical 
signs of anticoagulant poisoning, which an owner would be 
likely to detect, e.g., dullness, inappetence, spontaneous 
bleeding from orifices, sudden appearance of subcutaneous 
swelling, or hemorrhages in !he oral mucosa. Treatment 
commenced immediately clinical signs appeared and cons1i-
1uted daily IM injections of vitamin K1 (2 mg/kg) for 5 days. 
Based on !he results of a previous !rial (Godfrey, unpubl.) 
it was estimated lha15 days' therapy would be sufficiently long 
toreversebrodifacoum poisoning. However, it soon became 
apparent that 5 days was not long enough. A number of dogs 
became clinically affected a few days after the initial period 
of treaunent ended and further vitamin K1 doses were given 
when indicated by the development of clinical signs or pro-
longed P limes. Four dogs chosen at random served as 
controls 10 assess the severity of the relapse: dogs 40 and 51 
in Group I; 58 and 61 in Group 2. 
Blood samples were taken using citrated vacutainers al 
2 to 3 day intervals throughout the trial for deiermina!ion of 
P times using Simplas!in obtained from William R. Warner, 
Ltd. 
RESULTS 
Group I 
(Table I) The P times during !he initial treatment period 
rose slightly but did not exceed II seconds. At day 8, 3 days 
after the initial treatment ceased, P times rose markedly in 
4of5 dogsandbyday 11 thefiflhdog'sPtime hadalsorisen. 
Further treatments were given up to 20 days after dosing as 
indicated. One of the control dogs (40) died on day 18 while 
the other control dog (51) and the 3 treated dogs survived. 
Group2 
(Table 2) P times for 2 of the 6 dogs exceeded 11 
seconds during tile first 5 days of therapy. Further treatments 
were given up to 22daysafterdosing as indicated. A control 
dog (58) died on day 10, despite receiving treatment on day 
9, when it showed signs of acute blood loss. All other dogs 
survived. 
Groun3 
(Table 3) One dog (35) vomited its sandwich the eve-
ning afier !he trial commenced and had normal P times 
despile receiving no treatment. Two dogs (45 and 52) were 
found dead on days 3 and 5 without showing any abnormal 
clinical signs. Dog 45 was a pregnant bilch which had 
started whelping prematurely in the night and was found 
dead the next day after hemorrhaging from the uterus. The 
remaining 7 dogs all showed a variety of clinical signs of 
anticoagulant poisoning which included inappelence, frank 
hemorrhaging from nose or mouth, blood in the faeces or 
petechial hemorrhages in the oral or conjunctiva! mem-
branes. The 5-day treaunents commenced immediately 
Table I. Porthrombin times (seconds) and occasions(*) when dogs were trealed with Vitamin K, (intramuscular injection 
2mg/kg) commencing the day afier they received brodifacoum (15 mg/kg). 
Days 
Dogs -2 -1 0 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
36 5 6 
-· 
6* 
-· 
6* 
-· 
6 6 13 15* IO 12 9 6 - N 
40 6 - 6 -* 11* -· 7* 
-· 
7 - 12 - 21 28 34 D 
51 5 
-
6 -* 7* -· 6* 
-· 
7 - II 17 9 - 14 II 15 6 N 
55 6 - 5 
-· 
11• -· 7* 
-· 
6 - 15 - -* JO - 8 - 6 6* 7 5 N 
56 5 - 6 
-· 6* -· 6* -· 8 - 21 31* -* 8 17 16 • 8* 6 N 
N-= Normal (<10 second prolhrombin times) 
o~Dcad 
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Table 2. Prothrombin times (seconds) and occasions(*) when dogs were treated with Vitamin K1 (oral tablets I mg/kg) 
commencing the day after they received brodifacoum (15 mg/kg). 
Days 
Dogs 0 1 2 3 4 5 6 7 8 
58 6 -* 11* -* 35* -* - 44 -
59 6 -* 8* -* 10* -* -* 12* -* 
60 6 -* 8* -* 8* -* -* 
61 6 -* 10* -* 8* -* -
62 6 -* 11* -* 13* -* 
-
63 7 -* 8* -* 7* -* -* 
N =Normal (<IO second prothrombin times) 
D=Dcad 
7* -* 
16 -
14 -
8* -* 
9 10 11 12 
52*D 
7• -* 6 
10 -* 7 
16* - 15* -* 
13* 
-
10* -* 
8* -* 6 
after these signs were first observed between days 4 and 8. 
Additional treatments were given to dog 41 when the P times 
rose above 15 seconds. All other dogs• P times remained at 
normal levels after the 5-day treatment except for dog 39 
which went up to 14 seconds on day 18 but returned to normal 
13 14 15 16 17 18 19 20 21 22 23 24 
8 25 -* 9 6 6 N 
10 15 -* 48 -* 5 6 N 
13 -* 8 10 12 -* 7 N 
6 8 6 6 7 N 
6 6 6 5 7 N 
levels by day 20 without further treatmenL None of the dogs 
showed clinical signs of anticoagulant poisoning subsequent 
to the 5-day treatment period. 
Postmortem examinations of dogs 40, 58 and 52 showed 
massive intrathoracic hemorrhage. 
Table 3. Prol.hrombin times (seconds) and occasions(*) when dogs were treated with Vitamin K1 (intramuscular injection 
2 mg/kg) commencing when clinical signs of brodifacoum poisoning appeared. 
Days 
-2 -1 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 1617 1819 20 21 22 23 24 25 26 27 28 29 30 31 
Dogs 
35 6 - 6 - 5 - 6 - 6 - 6 - - 5 - N 
39 s - 6 - 12 - 25 - 17* -* 6* ·* -* 6 - 10 - 9 14 - 8 - 6 N 
41 6 - 6 - 13 • 21 * -* 7* -* 6* - - 12 - 17 - F -* - 7 - F* - 12 - - 29 - 17 - F* -* N 
45 6 - 6 - 17 D ----------------------------
46 5 - 6 - 12 - 20 -* 6* -* 7* -* 6 - 6 6 5 - 5 6 N 
49 6 
- 6 - 15 - 20 - 14 -* 8* -* -* 5* . 6 . 6 6- 6 - 5 N 
50 s 
-
6 - 12 - 20 - 17 -* 9* -* -* 6 - 6 - 6 6- 6 - 5 N 
52 6 
-
7 - 15 - 17 D 
53 4 
- 6 - 13 - 26 - 13 - 22* -* -* 7* -* 7 - 8 7- 7 - 6 N 
54 6 - 6 - 17 - 16 -* 11* -* 6* -* - 8 - 7 - 6 6- 5 - 6 N 
N == Nomial (<10 se<:0nd prothrombin times) 
D ==Dead, F =Failed to clot (>60 seconds) 
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DISCUSSION 
The dose rate of brodifacoum used in this experiment is 
potentially lethal for most dogs, being 4 times the LD"' and 
equivalent to an LD,. {Godfrey et al. 1981 b ). 
It was calculated to be the maximum acute dose a dog 
could reasonably consume at one time in the form of baits 
(i.e., 6-kg baits for a 20-kg dog). However, it would be 
relatively easy for this dose to be consumed over a period of 
a few days. 
The !rial was designed so that Groups 1 and 2 mimicked 
immediate prophylactic treaunent while Group 3 represented 
the emergency treaunent of dogs which have developed 
obvious clinical signs of anticoagulant poisoning. The results 
show that in the ease ofimmediate prophylactic therapy a 4-
5day vitamin K regime as recommended for treating warfarin 
poisoning in dogs (Clark and Halliwell 1963, Mount et al. 
1982) is of insufficient duration in cases of brodifacoum 
poisoning. 
The results also suggest that oral therapy with vitamin K1 
at a dose rate of l mg/kg is insufficient to maintain normal P 
times in dogs which have received a high dose of brod-
ifacoum. Clark and Halliwell (1963) demons!rated that oral 
and injectable forms of vitamin K, therapy both produced 
similar effects although the inttamuscular route gave a 
slightly slower onset of action but appeared to have a slight! y 
more prolonged effecL They concluded that with both routes 
dosage at 24-hour intervals should be sufficienL They 
recommended dose rates of 1 to 2 mg/kg to treat warfarin 
poisoning. The present trials suggest that 2 mg/kg for both 
oral and injectable routes should be used in cases of brod-
ifacoum poisoning. 
The 2 deaths in Group 3 demonstrate how rapidly the 
coagulation factors can be depleted leading to acute, massive 
hemorrhage and highlight the susceptibility of pregnant 
bitches to hemorrhage at whelping. 
In most cases 5 days' !reaunentof the clinically affected 
dogs was sufficient and suggests that there is little brod-
ifacoum activity after 10 or 11 days. Two dogs, whose last 
treatments were on days 8 and 10, each had a transient rise in 
Ptimes3 io8 days later. Dog 39 returned to normal 2to 3 days 
laterwithouttreaunent. However,dog41 wastreatedondays 
16, 20, 29 and 30, although not all of these may have been 
necessary as some of the Simplastin tests failed to clot, and 
the results appear to be anomalous because the animal 
showed no clinical signs of poisoning despite very prolonged 
Ptimes. 
RECOMMENDATIONS 
If a dog is known or thought to have eaten baits or dead 
animals containing brodifacoum, then vitamin K1 therapy, 2 
mg/kg either by IM injection or oral tablets, should be given 
daily for 3 weeks. Periodic blood samples for P time 
measurement may be taken to monitor the effectiveness of 
the treaunent 
If a dog develops clinical signs of anticoagulant poison-
ing, it must now be assumed to be due to brodifacoum and 
treated accordingly. If the dog shows signs of acute massive 
89 
hemorrhage, then it is advisable to give a !ran sf us ion of whole 
blood or plasma which should immediately supply he-
mostatic concentrations of clotting factors. The amount 
transferred should approximate 5-10% of the patient's total 
blood volume, which is approximately 90 ml/kg {Moumctal. 
1982). In cases ofhemothorax the blood should be aspirated 
and autolransfusion (where aspirated blood plus vitamin K1 
is transfused back into the dog) may be performed (Crispin 
1977). In acute cases, vitamin K1 (I mg/kg) diluted with 
saline may be given by slow inlravenous injection, and prior 
adminislration of an antihislaminc is recommended to pre-
vent hisiaminoid reactions (Clark and Halliwell 1963, 
Crispin 1977). This should restore a proportion of clotting 
factors within 2 hours. Tablets or intramuscular injections of 
vitamin K 1 may be used initially in less acute cases. Vitamin 
K1 therapy by IM injection or oral tablets (2 mg/kg) should 
continue for 3 weeks. The effectiveness of the lhcrapycan be 
monitored by measuring the P time. Pregnant bitches close 
lo whelping should receive particular attention to assure that 
their P time is <10 seconds when whelping begins. 
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